Literature DB >> 4690060

Clinical and genetic aspects of malignant hyperpyrexia.

K Kyei-Mensah, J H Tyrrell, D W Sumner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4690060      PMCID: PMC1644366     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  12 in total

1.  Myopathy and malignant hyperpyrexia.

Authors:  M A Denborough; P Ebeling; J O King; P Zapf
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

Review 2.  Malignant hyperthermia: a statistical review.

Authors:  B A Britt; W Kalow
Journal:  Can Anaesth Soc J       Date:  1970-07

3.  Malignant hyperthermia: a study of an affected family.

Authors:  D G Larard; C P Rice; R Robinson; R W Spencer; R A Westhead
Journal:  Br J Anaesth       Date:  1972-01       Impact factor: 9.166

4.  Fulminating hyperpyrexia during anaesthesia in a member of a myopathic family.

Authors:  A J Steers; J A Tallack; D E Thompson
Journal:  Br Med J       Date:  1970-05-09

5.  Serum creatine phosphokinase levels in pigs reacting abnormally to halogenated anaesthetics.

Authors:  N Woolf; L Hall; C Thorne; M Down; R Walker
Journal:  Br Med J       Date:  1970-08-15

6.  Hereditary aspects of malignant hyperthermia.

Authors:  B A Britt; W G Locher; W Kalow
Journal:  Can Anaesth Soc J       Date:  1969-03

7.  Malignant hyperpyrexia: a study of a family. Case report.

Authors:  K Kyei-Mensah; R Lockwood; J H Tyrrell; I H Willett
Journal:  Br J Anaesth       Date:  1971-08       Impact factor: 9.166

8.  Halothane-induced muscle contracture as a cause of hyperpyrexia.

Authors:  F R Ellis; D G Harriman; N P Keaney; K Kyei-Mensah; J H Tyrrell
Journal:  Br J Anaesth       Date:  1971-07       Impact factor: 9.166

9.  Unusual reaction to suxamethonium chloride.

Authors:  L W Hall; N Woolf; J W Bradley; D W Jolly
Journal:  Br Med J       Date:  1966-11-26

10.  Malignant hyperpyrexia during anaesthesia: possible association with subclinical myopathy.

Authors:  H Isaacs; M B Barlow
Journal:  Br Med J       Date:  1970-01-31
View more
  3 in total

1.  Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.

Authors:  B A Britt; L Endrenyi; P L Peters; F H Kwong; L Kadijevic
Journal:  Can Anaesth Soc J       Date:  1976-05

2.  A family with intussusception and malignant hyperthermia.

Authors:  D T Jolly; J C McKim; M H Corrin
Journal:  Can Med Assoc J       Date:  1982-10-15       Impact factor: 8.262

3.  The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility.

Authors:  B A Britt; L Endrenyi; W Kalow; P L Peters
Journal:  Can Anaesth Soc J       Date:  1976-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.